- Home
- CATO vs BEAT Comparison
CATO vs BEAT Comparison
Compare CATO & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- BEAT
- Stock Information
- Founded
- CATO 1946
- BEAT 2015
- Country
- CATO United States
- BEAT United States
- Employees
- CATO N/A
- BEAT N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- CATO Consumer Discretionary
- BEAT Technology
- Exchange
- CATO Nasdaq
- BEAT Nasdaq
- Market Cap
- CATO 59.2M
- BEAT 51.1M
- IPO Year
- CATO N/A
- BEAT 2021
- Fundamental
- Price
- CATO $2.87
- BEAT $1.29
- Analyst Decision
- CATO
- BEAT Buy
- Analyst Count
- CATO 0
- BEAT 1
- Target Price
- CATO N/A
- BEAT $8.00
- AVG Volume (30 Days)
- CATO 43.0K
- BEAT 169.5K
- Earning Date
- CATO 08-21-2025
- BEAT 08-13-2025
- Dividend Yield
- CATO 6.11%
- BEAT N/A
- EPS Growth
- CATO N/A
- BEAT N/A
- EPS
- CATO N/A
- BEAT N/A
- Revenue
- CATO $642,949,000.00
- BEAT N/A
- Revenue This Year
- CATO N/A
- BEAT N/A
- Revenue Next Year
- CATO N/A
- BEAT N/A
- P/E Ratio
- CATO N/A
- BEAT N/A
- Revenue Growth
- CATO N/A
- BEAT N/A
- 52 Week Low
- CATO $2.19
- BEAT $1.17
- 52 Week High
- CATO $6.70
- BEAT $3.48
- Technical
- Relative Strength Index (RSI)
- CATO 53.03
- BEAT 35.53
- Support Level
- CATO $2.73
- BEAT $1.49
- Resistance Level
- CATO $2.99
- BEAT $1.62
- Average True Range (ATR)
- CATO 0.18
- BEAT 0.11
- MACD
- CATO -0.02
- BEAT -0.03
- Stochastic Oscillator
- CATO 30.14
- BEAT 20.27
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.